ScholarIQanswers from OpenAlex & ORCID
Razelle Kurzrock
ResearcherPublications, citations & collaboration network
Razelle Kurzrock is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Razelle Kurzrock have?
ScholarIQindexed works
Razelle Kurzrock has 2,331 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Razelle Kurzrock have?
ScholarIQcitation count
Razelle Kurzrock has 89,112 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Razelle Kurzrock?
ScholarIQh-index
Razelle Kurzrock has an h-index of 145 in OpenAlex.
What is the i10-index of Razelle Kurzrock?
ScholarIQi10-index
Razelle Kurzrock has an i10-index of 894 in OpenAlex.
What is the ORCID of Razelle Kurzrock?
ScholarIQorcid
The ORCID for Razelle Kurzrock is on the source record.
What is the OpenAlex record for Razelle Kurzrock?
ScholarIQopenalex
The OpenAlex for Razelle Kurzrock is on the source record.
What are the most-cited papers on Razelle Kurzrock?
ScholarIQmost cited works
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel, Razelle Kurzrock
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg, Dale Frank, David Wu, Gordan Srkalović, David Simpson, Amy Liu, David M. Menke, Shanmuganathan Chandrakasan, Mary Jo Lechowicz, Raymond Wong, Sheila K. Pierson, Michele Paessler, Jean‐François Rossi, Makoto Ide, Jason R. Ruth, M.P. Croglio, Alexander Suarez, Vera P. Krymskaya, Amy Chadburn, Gisele W. B. Colleoni, Sunita D. Nasta, Raj Jayanthan, Christopher S. Nabel, Corey Casper, Angela Dispenzieri, Alexander Fosså, Dermot Kelleher, Razelle Kurzrock, Peter M. Voorhees, Ahmet Doǧan, Kazuyuki Yoshizaki, Frits van Rhee, Éric Oksenhendler, Elaine S. Jaffe, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodón, Jean‐Charles Soria, Raanan Berger, Wilson H. Miller, Eitan Rubin, Aleksandra Kugel, Apostolia M. Tsimberidou, Pierre Saintigny, Aliza Ackerstein, Irene Braña, Yohann Loriot, Mohammad Afshar, Vincent A. Miller, Fanny Wunder, Catherine Bresson, Jean-François Martini, Jacques Raynaud, John Mendelsohn, Gerald Batist, Amir Onn, Josep Tabernero, Richard L. Schilsky, Vladimir Lazar, J. Jack Lee, Razelle Kurzrock
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
Jeffrey R. Infante, Leslie A. Fecher, Gerald S. Falchook, Sujatha Nallapareddy, Michael S. Gordon, Carlos Becerra, Douglas J. DeMarini, Donna S. Cox, Yanmei Xu, Shannon R. Morris, Vijay Peddareddigari, Ngocdiep T. Le, Lowell L. Hart, Johanna C. Bendell, Gail Eckhardt, Razelle Kurzrock, Keith T. Flaherty, Howard A. Burris, Wells A. Messersmith